Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.

Latest updates to the Pembrolizumab in HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the lapse notice about government funding and the related Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding notice about the NIH Clinical Center status and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated status labels to 'Last Update Submitted that Met QC Criteria' with a 'No FEAR Act Data' indicator and revision 'v3.4.0'. The previous wording 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' term, and revision 'v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site revision was updated from v3.3.3 to v3.3.4, a minor UI/metadata update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe change updates the page revision label from v3.2.0 to v3.3.2 in the footer and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.